Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Queensland Health
Merck
McKesson
Healthtrust
Fish and Richardson
Boehringer Ingelheim
Fuji
Farmers Insurance

Generated: January 20, 2018

DrugPatentWatch Database Preview

Methazolamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methazolamide and what is the scope of methazolamide patent protection?

Methazolamide
is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Applied Anal, Mikart, Sandoz, and Lederle, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for methazolamide. Six suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for methazolamide

US Patents and Regulatory Information for methazolamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040102-002 Aug 28, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040102-001 Aug 28, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applied Anal METHAZOLAMIDE methazolamide TABLET;ORAL 040011-001 Jul 17, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle NEPTAZANE methazolamide TABLET;ORAL 011721-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040036-001 Jun 30, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc METHAZOLAMIDE methazolamide TABLET;ORAL 040001-002 Jun 30, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mikart METHAZOLAMIDE methazolamide TABLET;ORAL 040062-002 Jan 27, 1994 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mikart METHAZOLAMIDE methazolamide TABLET;ORAL 040062-001 Jan 27, 1994 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle NEPTAZANE methazolamide TABLET;ORAL 011721-002 Nov 25, 1991 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applied Anal METHAZOLAMIDE methazolamide TABLET;ORAL 040011-002 Jul 17, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Julphar
Accenture
Queensland Health
Colorcon
Dow
Harvard Business School
QuintilesIMS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot